Pioneer Vaccine
Pioneer Vaccine is dedicated to developing innovative vaccines to improve global health. Their mission is to create effective and safe vaccines to combat various diseases, contributing to better health outcomes worldwide.
Industries
Nr. of Employees
small (1-50)
Pioneer Vaccine
Yusong, Taejon-jikhalsi, South Korea, Asia
Products
불활화 분할 백신(1가)
Combination pentavalent vaccine consisting of monovalent COVID-19 and quadrivalent seasonal influenza inactivated split vaccines.
세포배양 기술을 이용한 계절 독감 불활화 분할 백신(4가)
Quadrivalent seasonal influenza inactivated split vaccine utilizing cell culture technology.
세포배양 기술을 이용한 코로나-19 불활화 분할 백신(1가) 및 계절 독감 불활화 분할 백신(4가) 혼합 5가 백신
Combination pentavalent vaccine consisting of monovalent COVID-19 and quadrivalent seasonal influenza inactivated split vaccines.
세포배양 기술을 이용한 코로나-19 불활화 분할 백신(1가)
Monovalent COVID-19 inactivated split vaccine utilizing cell culture technology.
생백신
Nasal spray COVID-19 live vaccine using Vero cell culture and cold-adapted attenuation technologies.
세포배양기술 (Vero)을 이용한 피하로 접종하는 뎅기열 바이러스 (Dengue virus) 생백신 (4가)
Tetravalent subcutaneous dengue virus live vaccine utilizing Vero cell culture technology.
불활화 분할 백신(1가)
Combination pentavalent vaccine consisting of monovalent COVID-19 and quadrivalent seasonal influenza inactivated split vaccines.
세포배양 기술을 이용한 계절 독감 불활화 분할 백신(4가)
Quadrivalent seasonal influenza inactivated split vaccine utilizing cell culture technology.
세포배양 기술을 이용한 코로나-19 불활화 분할 백신(1가) 및 계절 독감 불활화 분할 백신(4가) 혼합 5가 백신
Combination pentavalent vaccine consisting of monovalent COVID-19 and quadrivalent seasonal influenza inactivated split vaccines.
세포배양 기술을 이용한 코로나-19 불활화 분할 백신(1가)
Monovalent COVID-19 inactivated split vaccine utilizing cell culture technology.
생백신
Nasal spray COVID-19 live vaccine using Vero cell culture and cold-adapted attenuation technologies.
세포배양기술 (Vero)을 이용한 피하로 접종하는 뎅기열 바이러스 (Dengue virus) 생백신 (4가)
Tetravalent subcutaneous dengue virus live vaccine utilizing Vero cell culture technology.